Evidence map›Paper›PMID 36604425›Full record

ArticleNature communications2023

Improving cassava bacterial blight resistance by editing the epigenome.

Kira M Veley, Kiona Elliott, Greg Jensen, Zhenhui Zhong, Suhua Feng, Marisa Yoder, Kerrigan B Gilbert, Jeffrey C Berry, Zuh-Jyh Daniel Lin, Basudev Ghoshal and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
33.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Adaptive Responses of Tropical Crops: A Multi-Scale Omics Integrated Perspective.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Genome Editing in Root and Tuber Crop Development in Sub-Saharan Africa.Plant-environment interactions (Hoboken, N.J.) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. A Modular and Customizable CRISPR/Cas Toolkit for Epigenome Editing of Cis-regulatory Modules.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Kira M VeleyDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.ORCID 0000-0002-3109-5810
Kiona ElliottDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.
Greg JensenDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.
Zhenhui ZhongDepartment of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID 0000-0002-8438-0375
Suhua FengDepartment of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Marisa YoderDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.
Kerrigan B GilbertDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.ORCID 0000-0002-7164-5821
Jeffrey C BerryDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.ORCID 0000-0002-8064-9787
Zuh-Jyh Daniel LinDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.
Basudev GhoshalDepartment of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Javier Gallego-BartoloméDepartment of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Joanna NortonCollege of Tropical Agriculture & Human Resources, University of Hawaii at Manoa, Hilo, HI, 96720, USA.
Sharon Motomura-WagesCollege of Tropical Agriculture & Human Resources, University of Hawaii at Manoa, Hilo, HI, 96720, USA.
James C CarringtonDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA.ORCID 0000-0003-3572-129X
Steven E JacobsenDepartment of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, 90095, USA. jacobsen@ucla.edu.ORCID 0000-0001-9483-138X
Rebecca S BartDonald Danforth Plant Science Center, Saint Louis, MO, 63132, USA. rbart@danforthcenter.org.ORCID 0000-0003-1378-3481
Donald Danforth Plant Science Center · USUniversity of Hawaiʻi at Mānoa · USUniversity of California, Los Angeles · USAgriculture and Agri-Food Canada · CAHoward Hughes Medical Institute · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogens rely on expression of host susceptibility (S) genes to promote infection and disease. As DNA methylation is an epigenetic modification that affects gene expression, blocking access to S genes through targeted methylation could increase disease resistance. Xanthomonas phaseoli pv. manihotis, the causal agent of cassava bacterial blight (CBB), uses transcription activator-like20 (TAL20) to induce expression of the S gene MeSWEET10a. In this work, we direct methylation to the TAL20 effector binding element within the MeSWEET10a promoter using a synthetic zinc-finger DNA binding domain fused to a component of the RNA-directed DNA methylation pathway. We demonstrate that this methylation prevents TAL20 binding, blocks transcriptional activation of MeSWEET10a in vivo and that these plants display decreased CBB symptoms while maintaining normal growth and development. This work therefore presents an epigenome editing approach useful for crop improvement.

Indexed as

ManihotXanthomonasDisease ResistanceEpigenomePlant DiseasesTranscription FactorsTranscription Factors

Identifiers

PMID36604425
PMCPMC9816117
OpenAlexW4313557129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.